No Data
No Data
NC HEALTHCARE: 2024 INTERIM REPORT
The net profit of nc healthcare (01518.HK) in the first half of the year increased by 9.1% to 25.193 million RMB.
Hong Kong-listed nc healthcare (01518.HK) announced its interim performance for the period ending June of this year, with revenue of 0.416 billion RMB (the same as below), a year-on-year decrease of 0%. Net profit was 25.193 million RMB, a year-on-year increase of 9.1%; earnings per share were 0.05 RMB. No interim dividend will be distributed.
The mid-term attributable profit of nc healthcare (01518.HK) is 25.2 million yuan.
On August 27th, nc healthcare (01518.HK) announced that in the mid-term of 2024, the group's business recorded revenue of RMB 41.6 million, which was basically the same as the same period last year. The period profit attributable to owners of the company was RMB 2.52 million, compared with RMB 2.31 million in the same period of 2023, mainly due to (i) the company's implementation of expenditure control measures in 2024; and (ii) the net decrease in impairment losses on financial assets during the period compared to the first half of 2023.
nc healthcare (01518) released its interim results, with a attributable surplus of 25.193 million yuan, an increase of 9.07% year-on-year.
nc healthcare (01518) released its interim performance for the six months ended June 30, 2024, during which the group achieved...
NC HEALTHCARE: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
NC Healthcare (01518.HK) held a board of directors meeting on August 27 to consider and approve the announcement of its interim results.
NC Healthcare (01518.HK) announced that it will hold a board of directors meeting on August 27, 2024 (Tuesday) to consider and approve the publication of the company and its subsidiaries' interim performance for the six months ending on June 30, 2024, as well as to deal with other matters, including other considerations.
No Data